Molecular and immunological features of a prolonged exceptional responder with malignant pleural mesothelioma treated initially and rechallenged with pembrolizumab

BACKGROUND: This case represents an exceptional response to pembrolizumab in a patient with epithelioid mesothelioma with a further response on rechallenge. CASE PRESENTATION: A 77-year-old woman with advanced epithelioid mesothelioma extensively pretreated with chemotherapy demonstrated a prolonged...

Descripción completa

Detalles Bibliográficos
Autores principales: Minchom, Anna, Yuan, Wei, Crespo, Mateus, Gurel, Bora, Figueiredo, Ines, Wotherspoon, Andrew, Miranda, Susana, Riisnaes, Ruth, Ferreira, Ana, Bertan, Claudia, Pereira, Rita, Clarke, Matt, Baker, Chloe, Ang, Joo Ern, Fotiadis, Nicos, Tunariu, Nina, Carreira, Suzanne, Popat, Sanjay, O'Brien, Mary, Banerji, Udai, de Bono, Johann, Lopez, Juanita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069263/
https://www.ncbi.nlm.nih.gov/pubmed/32169873
http://dx.doi.org/10.1136/jitc-2020-000713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069263/
https://www.ncbi.nlm.nih.gov/pubmed/32169873
http://dx.doi.org/10.1136/jitc-2020-000713

Ejemplares similares